Coronary artery stent outcomes
Pro Research Analysisby 
Searched over 200M research papers
Coronary Artery Stent Outcomes: General Efficacy and Safety
Coronary artery stents are widely used to treat coronary artery disease, and research consistently shows that stenting improves both immediate and long-term outcomes compared to balloon angioplasty alone. Stents reduce the need for repeat procedures and lower restenosis rates, although they may increase the risk of vascular complications at the access site and lengthen hospital stays in the short term . Over three years, stented lesions show a low rate of revascularization, and some studies even report late improvement in vessel diameter, indicating durable benefits .
Drug-Eluting Stents and Long Lesions
For patients with diffuse coronary artery disease requiring long stents (≥40 mm), drug-eluting stents (DES) have demonstrated safety and efficacy, with low rates of target lesion failure, mortality, major adverse cardiovascular events (MACE), stent thrombosis, and in-stent restenosis at one year. Most patients experience uneventful follow-up, and smaller stent diameters are associated with higher risk of adverse outcomes . In very small vessels, sirolimus-eluting stents have shown excellent five-year safety and effectiveness, with low rates of cardiac events and no stent thrombosis .
Left Main Coronary Artery Stenting vs. Surgery
Stenting for unprotected left main coronary artery stenosis has been compared to coronary artery bypass grafting (CABG) in both randomized trials and observational studies. Over 10 years, stenting offers similar survival and MACE rates to surgery, with a trend toward better ejection fraction and MACCE-free survival, though differences are not statistically significant . Immediate and medium-term outcomes are also favorable, especially in patients at low surgical risk, with restenosis rates comparable to other coronary sites .
Covered Stents for Coronary Artery Perforation and Aneurysms
Covered stents, such as polytetrafluoroethylene (PTFE) and polyurethane-covered stents, are used in emergencies like coronary artery perforation and for treating coronary artery aneurysms. These stents are effective in sealing perforations and managing aneurysms, with high procedural success rates 16710. However, they are associated with higher rates of target lesion revascularization, stent thrombosis, and MACE during follow-up, especially in patients who develop cardiac tamponade 16710. Despite these risks, covered stents remain a crucial option in life-threatening situations.
Conclusion
Coronary artery stents, including drug-eluting and covered stents, provide effective treatment for a range of coronary artery conditions. Drug-eluting stents are safe and effective for both long lesions and small vessels, while stenting for left main disease offers outcomes comparable to surgery in selected patients. Covered stents are essential for managing perforations and aneurysms, though they carry higher risks of certain complications. Overall, stenting remains a cornerstone of coronary artery disease management, with ongoing improvements in safety and efficacy.
Sources and full results
Most relevant research papers on this topic